Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

High Fat Meal and Postprandial TG Levels With and Without Exercise Intervention

27 de janeiro de 2023 atualizado por: Sibylle Kranz, PhD, RDN, University of Virginia

The Effect of Moderate-Intensity Exercise on Postprandial Plasma Triglyceride Levels Following a High Fat Meal

The objective of this study is to investigate whether "real-life" bouts of MIE are effective at attenuating PPTL after a meal (either a keto-type brownie (KETO) or a high carb (CON) meal of pasta and sauce), compared to non-exercise control. The primary outcome of this study is the measured change in PPTL level from baseline (fasting) to 6 hours postprandial on each activity level. We hypothesize that MIE will decrease PPTL in comparison to rest. For our secondary outcomes, we expect greater decrease in blood pressure, blood glucose, and metabolic rates after the MIE exercise bouts. Finally, we expect that KETO will be rated as more satiating.

Visão geral do estudo

Status

Rescindido

Intervenção / Tratamento

Descrição detalhada

Cardiovascular disease (CVD) is the leading cause of death and disease in the United States with an overall prevalence of about 48% in adults >20 years of age. The Global Burden of Health assessment showed that CVD is largely attributed to dietary risks, followed by high systolic blood pressure (BP), high body mass index (BMI), high total cholesterol and fasting plasma triglycerides (TG), smoking, and inadequate physical activity. Increased plasma TG levels can promote atherosclerosis, atherosclerotic lesions, plaque formation, and heart attack. Consumption of high fat meals (HFM), which are very common in the American diet, likely increase postprandial triglyceride levels (PPTL), in proportion to the fat content of the meal. This is of particular concern because Americans, on average, have ~6 eating occasions throughout the day, thus maintaining a postprandial state of chronically high PPTL.

Additionally, a HFM has also been shown to negatively affect endothelial function, blood pressure, glycemic control, and resting metabolic rate. The decline in endothelial function is thought to be mediated by the oxidative stress caused by the elevated PPTL, which then contributes to proatherogenic state. Glycemic control was also found to be disrupted following consumption of a high fat meal likely due to a change in glucose absorption from the gut, glucose production in the liver, or glucose uptake from skeletal muscle. Conversely, blood pressure does not seem to be significantly affected by a high fat meal when measured up to 4 hours postprandial, although these findings are equivocal.

Recent studies have elucidated a potential role of exercise in attenuating the postprandial lipemia response via several proposed mechanisms including exercise-induced increase in fat oxidation, lipoprotein lipase (LPL) messenger ribonucleic acid (mRNA expression) and LPL activity, reduced hepatic VLDL secretions, and the creation of an energy deficit. LPL is responsible for breaking TGs down into free fatty acids, thus improving TG clearance rates. Exercise has also been shown to attenuate the increase in blood pressure and blood glucose caused by the high fat meal.

Previous studies have found that compared to a non-exercising control, moderate-intensity exercise (MIE) decreases PPTL by about 15.5% (p = 0.03) when performed prior to a HFM likely due to the increase in postprandial fat oxidation rate elicited by the exercise. Following exercise performed post-HFM, PPTL attenuation is believed to be due to a decrease in hepatic very low-density lipoprotein (VLDL) secretion, as studies have shown that hepatic VLDL concentrations decrease about 4.5 hours after exercising under post-absorptive conditions and circulating triglyceride (TG) levels of VLDL decrease by 30%. With the decrease in TG secretion, there is an increase in LPL activity that consequently increases TG clearance. Thus, as time between exercise bout and HFM consumption increases, LPL becomes an ever-increasingly important factor that further improves PPTL clearance. However, many studies have only investigated the effects of exercise prior to HFM consumption. Furthermore, many of these studies rely on exaggerated fat intake or energy expenditure in excess of the Physical Activity Guidelines for Americans. While there is one study that measured effects of exercise following a HFM, only moderate intensity (60% VO2peak) was used, and endothelial function was measured up to 4 hours postprandial the test meal and 2 hours following the exercise. However, the PPTL attenuation depends on the type of exercise, energy expenditure, intensity, energy balance, and timing relative to the HFM. Moderate intensity exercise (MIE), which is categorized as 65-75% of maximal heart rate, leads to an increase in glucose oxidation rates, which can potentially lead to a greater increase in fat oxidation in comparison to rest (no exercise) after a meal. While activity guidelines recommend engaging in either moderate or high intensity exercise, it remains unclear whether MIE changes PPTL differently after an HFM.

The objective of this study is to investigate whether "real-life" bouts of MIE are effective at attenuating PPTL after a meal (either a keto-type brownie (KETO) or a high carb (CON) meal of pasta and sauce), compared to non-exercise control. The primary outcome of this study is the measured change in PPTL level from baseline (fasting) to 6 hours postprandial on each activity level. We hypothesize that MIE will decrease PPTL in comparison to rest. For our secondary outcomes, we expect greater decrease in blood pressure, blood glucose, and metabolic rates after the MIE exercise bouts. Finally, we expect that KETO will be rated as more satiating.

This is a repeated measures cross-over design, in which all subjects will undergo rest (control) and two exercise protocols. The order of the exercise will be randomized using a traditional coin flip where each combination of flips results in a what meal/ exercise type the subject would be participating in that day. We will have an independent individual (not involved in the study) perform the study randomization and maintain the allocation schedule. Due to the nature of the exercise, blinding participants to the exercise intensity is not possible.

Tipo de estudo

Intervencional

Inscrição (Real)

7

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Virginia
      • Charlottesville, Virginia, Estados Unidos, 22904
        • University of Virginia

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 45 anos (Adulto)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • Male or female
  • 18-45 years old

Exclusion Criteria:

  • Food allergies (dairy, nuts, food dyes)
  • Orthopedic or musculoskeletal contraindications to exercise
  • Known cardiovascular, pulmonary, or metabolic disease
  • Metal implants that may interfere with bioelectrical impedance analysis
  • Answers "yes" to one or more questions on the Physical Activity Readiness Questionnaire
  • Current smoker
  • Blood pressure of 130/80 or higher
  • Meets or exceeds American College of Sports Medicine guidelines of engaging in 150min/wk of moderate intensity exercise or 75min/wk vigorous intensity exercise Unwilling or unable to follow all aspects of the study protocol
  • Female participants will have to confirm that they have a normal menstrual cycle (10-12 periods per year). If yes, they are only to participate during the follicular phase of the menstrual cycle (i.e., the week following the first day of menses).

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Prevenção
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição cruzada
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Diet: high fat meal
Participants will consume either a high fat or a high carbohydrate meal.
participants will consume a high fat (intervention) or high carbohydrate (control) meal.
Outros nomes:
  • Refeição com alto teor de gordura
Experimental: Exercise: medium intensity exercise
After consuming the meal, participants will either exercise at moderate intensity for 30 minutes or rest.
participants will exercise with medium intensity under supervision for 30 minutes (intervention) or rest (control) after consuming the meal.
Outros nomes:
  • Moderate intensity exercise bout

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Total Blood triglyceride levels as indicated by fasting triglycerides
Prazo: Baseline
The participant's hand will be turned upward and massaged to increase blood flow. After sanitizing, their index finger will be held in an upward position, and the lancet is placed firmly into the fingertip. The first drop of blood will be discarded. The next drop of blood, from the same fingerstick, will be placed in the device to read triglyceride levels.
Baseline
Total Blood triglyceride levels as indicated by postprandial triglycerides
Prazo: 2 hours postprandial
The participant's hand will be turned upward and massaged to increase blood flow. After sanitizing, their index finger will be held in an upward position, and the lancet is placed firmly into the fingertip. The first drop of blood will be discarded. The next drop of blood, from the same fingerstick, will be placed in the device to read triglyceride levels.
2 hours postprandial
Total Blood triglyceride levels as indicated by postprandial triglycerides
Prazo: 4 hours postprandial
The participant's hand will be turned upward and massaged to increase blood flow. After sanitizing, their index finger will be held in an upward position, and the lancet is placed firmly into the fingertip. The first drop of blood will be discarded. The next drop of blood, from the same fingerstick, will be placed in the device to read triglyceride levels.
4 hours postprandial
Total Blood triglyceride levels as indicated by postprandial triglycerides
Prazo: 5 hours postprandial
The participant's hand will be turned upward and massaged to increase blood flow. After sanitizing, their index finger will be held in an upward position, and the lancet is placed firmly into the fingertip. The first drop of blood will be discarded. The next drop of blood, from the same fingerstick, will be placed in the device to read triglyceride levels.
5 hours postprandial
Total Blood triglyceride levels as indicated by postprandial triglycerides
Prazo: 6 hours postprandial
The participant's hand will be turned upward and massaged to increase blood flow. After sanitizing, their index finger will be held in an upward position, and the lancet is placed firmly into the fingertip. The first drop of blood will be discarded. The next drop of blood, from the same fingerstick, will be placed in the device to read triglyceride levels.
6 hours postprandial

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Blood glucose level as indicated by fasting blood glucose
Prazo: Baseline
Blood glucose will be measured using the device for finger prick blood sampling after arriving in the lab and hourly after consuming the meal.
Baseline
Finger prick blood sample for blood glucose level as indicated by postprandial blood glucose
Prazo: 2 hours postprandial
Blood glucose will be measured using the device for finger prick blood sampling after arriving in the lab and hourly after consuming the meal.
2 hours postprandial
Finger prick blood sample for blood glucose level as indicated by postprandial blood glucose
Prazo: 4 hours postprandial
Blood glucose will be measured using the device for finger prick blood sampling after arriving in the lab and hourly after consuming the meal.
4 hours postprandial
Finger prick blood sample for blood glucose level as indicated by postprandial blood glucose
Prazo: 5 hours postprandial
Blood glucose will be measured using the device for finger prick blood sampling after arriving in the lab and hourly after consuming the meal.
5 hours postprandial
Finger prick blood sample for blood glucose level as indicated by postprandial blood glucose
Prazo: 6 hours postprandial
Blood glucose will be measured using the device for finger prick blood sampling after arriving in the lab and hourly after consuming the meal.
6 hours postprandial
Systolic and diastolic Blood pressure
Prazo: Baseline to 6 hours postprandial in 15 minute increments
A Bluetooth blood pressure cuff will also be given to the participant that they will wear continuously throughout the visit; data from the device will be taken at the end of the visit for 15-minute intervals.
Baseline to 6 hours postprandial in 15 minute increments
Indirect Calorimetry: Resting Metabolic Rate
Prazo: Baseline
Participant will lay at rest for 15 minutes prior to starting the test. A metabolic mask will then be placed over their mouth to analyze their oxygen and carbon dioxide usage to estimate their resting metabolic rate and respiratory exchange ratio. This will take about 30 minutes.
Baseline
Indirect Calorimetry: Resting Metabolic Rate
Prazo: 2 hour postprandial
Participant will lay at rest for 15 minutes prior to starting the test. A metabolic mask will then be placed over their mouth to analyze their oxygen and carbon dioxide usage to estimate their resting metabolic rate and respiratory exchange ratio. This will take about 30 minutes.
2 hour postprandial
Indirect Calorimetry: Resting Metabolic Rate
Prazo: 3 hour postprandial
Participant will lay at rest for 15 minutes prior to starting the test. A metabolic mask will then be placed over their mouth to analyze their oxygen and carbon dioxide usage to estimate their resting metabolic rate and respiratory exchange ratio. This will take about 30 minutes.
3 hour postprandial
Indirect Calorimetry: Resting Metabolic Rate
Prazo: 4 hour postprandial
Participant will lay at rest for 15 minutes prior to starting the test. A metabolic mask will then be placed over their mouth to analyze their oxygen and carbon dioxide usage to estimate their resting metabolic rate and respiratory exchange ratio. This will take about 30 minutes.
4 hour postprandial
Indirect Calorimetry: Resting Metabolic Rate
Prazo: 5 hour postprandial
Participant will lay at rest for 15 minutes prior to starting the test. A metabolic mask will then be placed over their mouth to analyze their oxygen and carbon dioxide usage to estimate their resting metabolic rate and respiratory exchange ratio. This will take about 30 minutes.
5 hour postprandial
Indirect Calorimetry: Resting Metabolic Rate
Prazo: 6 hour postprandial
Participant will lay at rest for 15 minutes prior to starting the test. A metabolic mask will then be placed over their mouth to analyze their oxygen and carbon dioxide usage to estimate their resting metabolic rate and respiratory exchange ratio. This will take about 30 minutes.
6 hour postprandial
Indirect Calorimetry: Respiratory Exchange Ratio
Prazo: Baseline
Participant will lay at rest for 15 minutes prior to starting the test. A metabolic mask will then be placed over their mouth to analyze their oxygen and carbon dioxide usage to estimate their resting metabolic rate and respiratory exchange ratio. This will take about 30 minutes.
Baseline
Indirect Calorimetry: Respiratory Exchange Ratio
Prazo: 2 hours postprandial
Participant will lay at rest for 15 minutes prior to starting the test. A metabolic mask will then be placed over their mouth to analyze their oxygen and carbon dioxide usage to estimate their resting metabolic rate and respiratory exchange ratio. This will take about 30 minutes.
2 hours postprandial
Indirect Calorimetry: Respiratory Exchange Ratio
Prazo: 3 hours postprandial
Participant will lay at rest for 15 minutes prior to starting the test. A metabolic mask will then be placed over their mouth to analyze their oxygen and carbon dioxide usage to estimate their resting metabolic rate and respiratory exchange ratio. This will take about 30 minutes.
3 hours postprandial
Indirect Calorimetry: Respiratory Exchange Ratio
Prazo: 4 hours postprandial
Participant will lay at rest for 15 minutes prior to starting the test. A metabolic mask will then be placed over their mouth to analyze their oxygen and carbon dioxide usage to estimate their resting metabolic rate and respiratory exchange ratio. This will take about 30 minutes.
4 hours postprandial
Indirect Calorimetry: Respiratory Exchange Ratio
Prazo: 5 hours postprandial
Participant will lay at rest for 15 minutes prior to starting the test. A metabolic mask will then be placed over their mouth to analyze their oxygen and carbon dioxide usage to estimate their resting metabolic rate and respiratory exchange ratio. This will take about 30 minutes.
5 hours postprandial
Indirect Calorimetry: Respiratory Exchange Ratio
Prazo: 6 hours postprandial
Participant will lay at rest for 15 minutes prior to starting the test. A metabolic mask will then be placed over their mouth to analyze their oxygen and carbon dioxide usage to estimate their resting metabolic rate and respiratory exchange ratio. This will take about 30 minutes.
6 hours postprandial

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Publicações Gerais

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

28 de março de 2022

Conclusão Primária (Real)

1 de novembro de 2022

Conclusão do estudo (Real)

1 de novembro de 2022

Datas de inscrição no estudo

Enviado pela primeira vez

3 de março de 2022

Enviado pela primeira vez que atendeu aos critérios de CQ

13 de março de 2022

Primeira postagem (Real)

23 de março de 2022

Atualizações de registro de estudo

Última Atualização Postada (Real)

31 de janeiro de 2023

Última atualização enviada que atendeu aos critérios de controle de qualidade

27 de janeiro de 2023

Última verificação

1 de janeiro de 2023

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • HSR210163

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever